Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Breast Cancer Characterization and Neoadjuvant Chemotherapy Monitoring u sing Diffuse Optical Methods

Open Access Open Access


We have quantified optical contrast of various tumor type (N=34) with a clinical diffuse optical tomography system. Also, we have monitored neoadjuvant chemothe rapy response which agreed well with MRI.

© 2006 Optical Society of America

PDF Article
More Like This
Neoadjuvant Chemtherapy Monitoring with Diffuse Optical Measurement of Blood Flow in Breast Tumors

Regine Choe, Chao Zhou, Turgut Durduran, Guoqiang Yu, Natasha Shah, Amanda Durkin, Albert Cerussi, Bruce J. Tromberg, and A. G. Yodh
SH27 Biomedical Topical Meeting (BIO) 2006

In Vivo Breast Cancer Characterization and Therapy Monitoring using Diffuse Optical Methods based on Endogenous Optical/Exogenous Fluorescence Contrast

Regine Choe, Soren D. Konecky, Alper Corlu, Kijoon Lee, Turgut Durduran, Chao Zhou, Brian J. Czerniecki, Julia C. Tchou, Angela DeMichele, Mark A. Rosen, Mitchell D. Schnall, Britton Chance, and A. G. Yodh
BSuB1 Biomedical Optics (BIOMED) 2008

Computer Aided Monitoring of Neoadjuvant Chemotherapy for Breast Cancer

David R. Busch, Wensheng Guo, Regine Choe, Turgut Durduran, Michael D. Feldman, Carolyn Mies, Brian J. Czerniecki, Julia Tchou, Angela DeMichele, Mark A. Rosen, Michael D. Schnall, and Arjun G. Yodh
BSu5A.7 Biomedical Optics (BIOMED) 2012

Select as filters

Select Topics Cancel
© Copyright 2022 | Optica Publishing Group. All Rights Reserved